Retrieve available abstracts of 46 articles: HTML format
Single Articles
June 2025
LI S, Lin J, Huang L, Hu S, et al STK31 drives tumor immune evasion through STAT3-IL-6 mediated CD8(+) T cell
exhaustion.
Oncogene. 2025;44:1452-1462. PubMedAbstract available
May 2025
WANG C, Zhang S, Ma B, Fu Y, et al Correction: TP53 mutations upregulate RCP expression via Sp1/3 to drive lung
cancer progression.
Oncogene. 2025 May 14. doi: 10.1038/s41388-025-03441. PubMed
WANG T, Shen Z, Yang L, Zhang X, et al The coagulation and tumor system are directly linked through the proteolysis and
activation of epidermal growth factor receptor by thrombin.
Oncogene. 2025;44:1153-1166. PubMedAbstract available
ZHANG C, Zhou W, Xu H, Xu J, et al Cancer-associated fibroblasts promote EGFR-TKI resistance via the
CTHRC1/glycolysis/H3K18la positive feedback loop.
Oncogene. 2025;44:1400-1414. PubMedAbstract available
April 2025
LIU X, Cui Y, Gong J, Yu X, et al SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2
stabilization in non-small cell lung cancer.
Oncogene. 2025 Apr 30. doi: 10.1038/s41388-025-03426. PubMedAbstract available
XU X, Wang S, Zhou H, Tan Q, et al Transcriptome-wide association study of alternative polyadenylation identifies
susceptibility genes in non-small cell lung cancer.
Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03338. PubMedAbstract available
March 2025
ZHANG S, Tan YQ, Zhang X, Basappa B, et al TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma.
Oncogene. 2025;44:753-768. PubMedAbstract available
February 2025
LI H, Li Y, Zheng X, Chen F, et al RBM15 facilitates osimertinib resistance of lung adenocarcinoma through
m6A-dependent epigenetic silencing of SPOCK1.
Oncogene. 2025;44:307-321. PubMedAbstract available
January 2025
ZEESHAN S, Dalal B, Arauz RF, Zingone A, et al Global profiling of alternative splicing in non-small cell lung cancer reveals
novel histological and population differences.
Oncogene. 2025 Jan 10. doi: 10.1038/s41388-024-03267. PubMedAbstract available
TYAGI A, Wu SY, Sharma S, Wu K, et al Retraction Note: Exosomal miR-4466 from nicotine-activated neutrophils promotes
tumor cell stemness and metabolism in lung cancer metastasis.
Oncogene. 2025 Jan 9. doi: 10.1038/s41388-024-03269. PubMed
December 2024
LEI Y, Zhong C, Zhang J, Zheng Q, et al Senescent lung fibroblasts in idiopathic pulmonary fibrosis facilitate non-small
cell lung cancer progression by secreting exosomal MMP1.
Oncogene. 2024 Dec 11. doi: 10.1038/s41388-024-03236. PubMedAbstract available
TANG T, Yang T, Xue H, Liu X, et al Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche
formation and promotes lung metastasis.
Oncogene. 2024 Dec 4. doi: 10.1038/s41388-024-03237. PubMedAbstract available
CHEN Y, Zhu X, Wang J, Hu J, et al MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma.
Oncogene. 2024;43:3619-3632. PubMedAbstract available
November 2024
CHEN T, Ashwood LM, Kondrashova O, Strasser A, et al Breathing new insights into the role of mutant p53 in lung cancer.
Oncogene. 2024 Nov 20. doi: 10.1038/s41388-024-03219. PubMedAbstract available
NIU Y, Tang Y, Ma F, Zhou X, et al Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by
recruiting transcription factors CTCF and KLF15.
Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03202. PubMedAbstract available
September 2024
LAILLER C, Didelot A, Garinet S, Berthou H, et al PrP(C) controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC:
implications for TKI resistance and patient follow-up.
Oncogene. 2024;43:2781-2794. PubMedAbstract available
HAN P, Zhang B, Li Y, Gao R, et al MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting
hypoxia adaptation mediated by HIF-1alpha/NDUFA4L2 axis.
Oncogene. 2024;43:2821-2834. PubMedAbstract available
August 2024
NGUYEN A, Nunez CG, Tran TA, Girard L, et al Jumonji histone demethylases are therapeutic targets in small cell lung cancer.
Oncogene. 2024 Aug 18. doi: 10.1038/s41388-024-03125. PubMedAbstract available
CHEN X, Zhou J, Wang Y, Wang X, et al PIM1/NF-kappaB/CCL2 blockade enhances anti-PD-1 therapy response by modulating
macrophage infiltration and polarization in tumor microenvironment of NSCLC.
Oncogene. 2024;43:2517-2530. PubMedAbstract available
SHEN NX, Luo MY, Gu WM, Gong M, et al GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via
deglutathionylation of NPM1 in lung adenocarcinoma.
Oncogene. 2024;43:2504-2516. PubMedAbstract available
July 2024
WANG Z, Lei Z, Wang Y, Wang S, et al Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with
macrophages to promote their dissemination.
Oncogene. 2024;43:2215-2227. PubMedAbstract available
June 2024
JIN E, Wang S, Chen D, Wang JP, et al P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung
adenocarcinoma cell growth.
Oncogene. 2024;43:1813-1823. PubMedAbstract available
LI QQ, Guo M, He GH, Xi KH, et al VEGF-induced Nrdp1 deficiency in vascular endothelial cells promotes cancer
metastasis by degrading vascular basement membrane.
Oncogene. 2024;43:1836-1851. PubMedAbstract available
WANG K, Guo D, Yan T, Sun S, et al ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1
transcription in lung adenocarcinoma.
Oncogene. 2024;43:1796-1810. PubMedAbstract available
CHEN L, Zhang L, He H, Shao F, et al Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to
inhibit lung adenocarcinoma progression by modifying p53 degradation.
Oncogene. 2024;43:2025-2037. PubMedAbstract available
May 2024
DORE S, Ali M, Sorin M, McDowell SAC, et al Exploring the prognostic significance of arm-level copy number alterations in
triple-negative breast cancer.
Oncogene. 2024 May 14. doi: 10.1038/s41388-024-03051. PubMedAbstract available
April 2024
WANG X, Li X, Niu L, Lv F, et al FAK-LINC01089 negative regulatory loop controls chemoresistance and progression
of small cell lung cancer.
Oncogene. 2024 Apr 9. doi: 10.1038/s41388-024-03027. PubMedAbstract available
ZHANG T, Su F, Wang B, Liu L, et al Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor
5 to augment malignant progression of lung adenocarcinoma.
Oncogene. 2024;43:1190-1202. PubMedAbstract available
March 2024
GUO J, Kim D, Gao J, Kurtyka C, et al Retraction Note: IKBKE is induced by STAT3 and tobacco carcinogen and determines
chemosensitivity in non-small cell lung cancer.
Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02993. PubMed
XU X, Qiu S, Zeng B, Huang Y, et al N(6)-methyladenosine demethyltransferase FTO mediated m(6)A modification of
estrogen receptor alpha in non-small cell lung cancer tumorigenesis.
Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02992. PubMedAbstract available
KUMAR V, Yochum ZA, Devadassan P, Huang EH, et al TWIST1 is a critical downstream target of the HGF/MET pathway and is required for
MET driven acquired resistance in oncogene driven lung cancer.
Oncogene. 2024 Mar 1. doi: 10.1038/s41388-024-02987. PubMedAbstract available
MCCLELLAN B, Wilson CN, Brenner AJ, Jolly CA, et al Flotillin-1 palmitoylation is essential for its stability and subsequent tumor
promoting capabilities.
Oncogene. 2024;43:1063-1074. PubMedAbstract available
HEIM TE, Hankins ML, Belayneh R, Douglas N, et al RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase
1A1 in osteosarcoma lung metastases.
Oncogene. 2024;43:1007-1018. PubMedAbstract available
February 2024
GAROFALO M, Quintavalle C, Di Leva G, Zanca C, et al Editorial Expression of Concern: MicroRNA signatures of TRAIL resistance in human
non-small cell lung cancer.
Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02989. PubMed
TURKOWSKI K, Herzberg F, Gunther S, Weigert A, et al miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02969. PubMedAbstract available
January 2024
ZHANG Y, Liu L, Pei J, Ren Z, et al Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in
non-small cell lung cancer.
Oncogene. 2024 Jan 8. doi: 10.1038/s41388-023-02924. PubMedAbstract available
OSER MG, MacPherson D, Oliver TG, Sage J, et al Genetically-engineered mouse models of small cell lung cancer: the next
generation.
Oncogene. 2024 Jan 8. doi: 10.1038/s41388-023-02929. PubMedAbstract available
MA M, Zhuang J, Li H, Mi R, et al Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting
the SDC4-TGF-beta signaling feedback loop.
Oncogene. 2024;43:47-60. PubMedAbstract available
December 2023
WANG L, Li H, Huang A, Zhao Y, et al Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination.
Oncogene. 2023;42:3708-3718. PubMedAbstract available
November 2023
CHEN W, Wang F, Yu X, Qi J, et al LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer
via H3K4me1- and H3K27Ace-mediated GLI2 expression.
Oncogene. 2023 Nov 10. doi: 10.1038/s41388-023-02883. PubMedAbstract available
KOU F, Wu L, Zheng Y, Yi Y, et al HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis
in lung adenocarcinoma.
Oncogene. 2023;42:3407-3421. PubMedAbstract available
SUN X, Dai Y, He J, Li H, et al D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the
progression of NSCLC.
Oncogene. 2023;42:3503-3513. PubMedAbstract available
October 2023
BAI Y, Zhou L, Zhang C, Guo M, et al Dual network analysis of transcriptome data for discovery of new therapeutic
targets in non-small cell lung cancer.
Oncogene. 2023 Oct 20. doi: 10.1038/s41388-023-02866. PubMedAbstract available
LIU Y, Zhang T, Deng J, Huang Q, et al The cytotoxicity of (gammadelta)T cells in non-small cell lung cancer mediated via
coordination of the BCL-2 and AKT pathways.
Oncogene. 2023 Oct 7. doi: 10.1038/s41388-023-02852. PubMedAbstract available
WANG Y, Liu X, Wang M, Wang Y, et al UBE3B promotes breast cancer progression by antagonizing HIF-2alpha degradation.
Oncogene. 2023 Oct 2. doi: 10.1038/s41388-023-02842. PubMedAbstract available
CUI P, Li J, Tao H, Li X, et al Deciphering pathogenic cellular module at single-cell resolution in checkpoint
inhibitor-related pneumonitis.
Oncogene. 2023;42:3098-3112. PubMedAbstract available